Wave Life Sciences
75 hedge funds and large institutions have $477M invested in Wave Life Sciences in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 6 closing their positions.
465% more call options, than puts
Call options by funds: $1.23M | Put options by funds: $217K
233% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 6
96% more capital invested
Capital invested by funds: $243M → $477M (+$234M)
23% more funds holding
Funds holding: 61 → 75 (+14)
0.92% more ownership
Funds ownership: 77.47% → 78.39% (+0.92%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$19M |
| 2 |
DKCM
Davidson Kempner Capital Management
New York
|
+$4.47M |
| 3 |
Millennium Management
New York
|
+$3.5M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.51M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
M28 Capital Management
Stamford,
Connecticut
|
-$9.58M |
| 2 |
6CM
683 Capital Management
New York
|
-$7.48M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.47M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$3.26M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.6M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
D.E. Shaw & Co
New York
| – | -$1.11M | -307,175 | Closed |
|
77
Group One Trading
Chicago,
Illinois
| – | -$140K | -30,316 | Closed |
|
|
CANY
78
Caxton Associates (New York)
New York
| – | -$87K | -24,013 | Closed |
|
|
LP
79
LMR Partners
London,
United Kingdom
| – | -$57K | -15,789 | Closed |
|
|
XT
80
XTX Topco
George Town,
Cayman Islands
| – | -$41K | -11,335 | Closed |
|
WVE Hedge Fund Activity: Q4 2022 in Review
75 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q4 2022, worth a combined $477M — up 96% from $243M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new WVE positions and 6 closed out — a net gain of 14 holders — while 21 added to existing stakes and 21 trimmed.
The largest buyer was Adage Capital Partners, adding an estimated $19M. The largest seller was M28 Capital Management, cutting an estimated $9.58M.
- 75 institutional investors held Wave Life Sciences (WVE) as of Q4 2022, up from 61 in Q3 2022.
- Funds reported $477M of Wave Life Sciences stock for Q4 2022, up 96% quarter-over-quarter.
- 20 funds opened new Wave Life Sciences positions in Q4 2022 and 6 closed out, a net change of +14 holders.
- The largest Wave Life Sciences buyer in Q4 2022 was Adage Capital Partners, an estimated $19M added.
- The largest Wave Life Sciences seller in Q4 2022 was M28 Capital Management, an estimated $9.58M sold.
Based on aggregated 13F filings for Q4 2022.